Silva Pharmaceuticals Limited: As per audited annual financial statements, Profit after tax was Tk. 92.99 million and basic EPS was Tk. 0.93 for the year ended on 30 June 2018 as against profit after tax of Tk. 80.28 million and basic EPS of Tk. 1.03 for the previous year ended on 30 June 2017. However, Post-IPO basic EPS for the year ended on 30 June 2018 would be Tk. 0.72. (cont.)